 |
Journal articles
IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats
Abstract : Insulin-like Growth Factor 1 (IGF-1) has broad-range neuroprotective effects and is a therapeutic candidate for Huntington’s disease (HD). IGF-1 protects striatal neurons from the toxicity of mutated huntingtin $in\ vitro$ and improves neuronal survival $in\ vivo$ in a phenotypic model of HD involving excitotoxic cell death. Because HD is a multifactorial disease, it is important to evaluate the neuroprotective role of IGF-1 in other pathological situations involved in HD progression. We have evaluated the neuroprotective effects of IGF-1 $in\ vivo$, using the 3-nitropropionic acid (3NP) rat model which replicates the mitochondrial dysfunction observed in HD. Continuous intracerebroventricular infusion of recombinant IGF-1 at a low dose (0.025 $\mu$g/h for 5 days) did not alleviate motor impairment and weight loss induced by 3NP treatment. In addition, histological evaluation and quantification of DNA fragmentation evidenced no improvement in neuronal survival. Of interest, we found that a higher concentration of IGF-1 (0.25 $\mu$g/h) resulted in an exacerbation of 3NP toxicity on striatal neurons. These results suggest that intracerebral delivery of IGF-1 may not provide a fully effective therapeutic strategy for HD or other disorders involving mitochondrial impairment
Cited literature [29 references]
https://hal-cea.archives-ouvertes.fr/cea-02290618
Contributor : Carole Escartin <>
Submitted on : Tuesday, September 17, 2019 - 5:55:47 PM
Last modification on : Monday, December 7, 2020 - 11:00:09 AM
Long-term archiving on: : Saturday, February 8, 2020 - 11:06:10 PM
Contributor : Carole Escartin <>
Submitted on : Tuesday, September 17, 2019 - 5:55:47 PM
Last modification on : Monday, December 7, 2020 - 11:00:09 AM
Long-term archiving on: : Saturday, February 8, 2020 - 11:06:10 PM
File
escartin-neuroscilett-2007.pdf
Explicit agreement for this submission